Hormone Replacement Therapy (HRT): Types, Evidence, Risks, Who It Helps, and What to Ask Your Doctor
At a Glance
- What it is: Hormone replacement therapy (HRT) restores hormones your body no longer produces in sufficient amounts, most commonly estrogen, progesterone, and testosterone.
- Who it helps: Women in menopause or perimenopause, women who have had surgical menopause (hysterectomy/oophorectomy), and men with clinically low testosterone.
- Delivery methods: Patches, pills, pellets, creams, gels, injections, and vaginal rings.
- Bioidentical vs. synthetic: Bioidentical hormones are chemically identical to what your body makes. Synthetic versions have a different molecular structure.
- Safety: Modern evidence shows HRT started within 10 years of menopause onset is safe for most women and carries significant benefits. Risk profiles change with age and timing.
- Cost: $30 to $500+ per month depending on type, delivery method, and whether you use insurance.
What Is Hormone Replacement Therapy?
Your body runs on hormones. They regulate everything from your mood and energy to your bone density, heart health, and sex drive. When hormone levels drop, whether from aging, surgery, or medical conditions, the effects can be dramatic. Brain fog, hot flashes, weight gain, insomnia, depression, loss of muscle mass: these are not just inconveniences. They erode your quality of life.
Hormone replacement therapy (HRT) is exactly what it sounds like. It replaces the hormones your body is no longer making in adequate quantities. For women, that typically means estrogen and progesterone. For men, it usually means testosterone (often called TRT, or testosterone replacement therapy). Some protocols include DHEA, thyroid hormones, or pregnenolone as well.
HRT has been around for decades, but its reputation took a serious hit in 2002 when one study scared millions of women off their prescriptions. We will get into that (and why modern medicine has largely reversed that panic) later in this page. For now, know this: when prescribed correctly, monitored properly, and started at the right time, HRT is one of the most effective treatments available for hormonal decline.
Types of Hormone Replacement Therapy
Bioidentical vs. Synthetic Hormones
This is the first decision point, and it matters more than most people realize.
Bioidentical hormones are molecularly identical to the hormones your ovaries, testes, and adrenal glands produce naturally. They are derived from plant sources (typically soy or yams) and then modified in a lab to match your body’s own chemistry exactly. Common examples include estradiol (the primary estrogen your ovaries make), micronized progesterone, and testosterone.
Synthetic hormones have a different molecular structure. Premarin (conjugated equine estrogens, derived from pregnant horse urine) and Provera (medroxyprogesterone acetate) are the most well-known examples. They activate the same receptors as your natural hormones, but because their shape is slightly different, they can produce different side-effect profiles.
Most integrative and functional medicine doctors now prefer bioidentical hormones. The research consistently shows a better safety profile, particularly for progesterone. Micronized progesterone (brand name Prometrium) does not carry the same breast cancer risk signal that synthetic progestins showed in the WHI study.
The Key Hormones in HRT
Estrogen is the primary female sex hormone. It protects bones, supports cardiovascular health, keeps skin elastic, maintains vaginal and urinary tract tissue, and plays a critical role in brain function. Estrogen replacement is the single most effective treatment for hot flashes, night sweats, and vaginal dryness.
Progesterone balances estrogen’s effects on the uterine lining. Any woman with an intact uterus who takes estrogen must also take progesterone to prevent endometrial hyperplasia (overgrowth of the uterine lining, which can lead to cancer). Progesterone also has calming, sleep-promoting properties that many women appreciate.
Testosterone is not just for men. Women produce testosterone too, and levels decline with age. Low testosterone in women can cause low libido, fatigue, and loss of muscle mass. In men, testosterone replacement (TRT) addresses hypogonadism and its related symptoms: fatigue, depression, erectile dysfunction, loss of strength, and cognitive decline.
Delivery Methods Compared
| Method | Hormones Available | Pros | Cons |
|---|---|---|---|
| Transdermal patch | Estrogen, testosterone | Steady levels, bypasses liver, lower clot risk | Can irritate skin, may fall off |
| Topical cream/gel | Estrogen, progesterone, testosterone | Easy to apply, adjustable dosing | Can transfer to others via skin contact, absorption varies |
| Oral pills | Estrogen, progesterone | Convenient, well-studied | First-pass liver metabolism, slightly higher clot risk for estrogen |
| Subcutaneous pellets | Estrogen, testosterone | Lasts 3 to 6 months, very steady levels | Requires minor in-office procedure, hard to adjust dose once placed |
| Injections | Testosterone, estrogen (less common) | Precise dosing, reliable absorption | Peaks and troughs between doses, requires needles |
| Vaginal ring/cream/tablet | Estrogen | Targets local symptoms, minimal systemic absorption | Only treats vaginal/urinary symptoms |
There is no single “best” delivery method. Your doctor should help you choose based on your symptoms, health history, lifestyle, and preferences. Many women start with patches or creams because they bypass the liver and carry the lowest risk of blood clots.
Who Is HRT For?
Women in Menopause
The average age of menopause in the US is 51. By this point, estrogen and progesterone production has dropped dramatically. Common symptoms include hot flashes, night sweats, sleep disruption, mood changes, vaginal dryness, painful intercourse, urinary urgency, joint pain, and difficulty concentrating. HRT addresses all of these.
Women in Perimenopause
Perimenopause can begin as early as your late 30s and typically starts in the mid-40s. Hormone levels fluctuate wildly during this phase. You might have cycles that are suddenly heavier, lighter, closer together, or further apart. Sleep worsens. Anxiety spikes. Many women are told “you are too young for menopause” and sent home without help. Perimenopause is actually one of the best times to start HRT, because intervening early can prevent bone loss and protect cardiovascular health.
Surgical Menopause
Women who have had their ovaries removed (oophorectomy) experience an immediate, dramatic drop in hormones. This is surgical menopause, and the symptoms are often more severe than natural menopause because the decline happens overnight rather than gradually. HRT is strongly recommended for these women, especially if surgery happens before age 45, to protect bone and brain health.
Men with Low Testosterone
Testosterone in men declines roughly 1% per year after age 30. Some men maintain adequate levels well into old age; others drop low enough to cause real problems by their 40s or 50s. Symptoms of low T include persistent fatigue, low motivation, reduced muscle mass, increased body fat (especially belly fat), erectile dysfunction, depression, and brain fog. When bloodwork confirms low levels, testosterone replacement therapy can be life-changing. We cover TRT in detail on our dedicated TRT page.
The Evidence: What the Research Actually Shows
The WHI Study and Its Fallout
In 2002, the Women’s Health Initiative (WHI) trial made global headlines. The study found that women taking a specific combination of conjugated equine estrogen (Premarin) plus synthetic progestin (Provera) had slightly elevated rates of breast cancer, heart attack, and stroke. Panic followed. Millions of women abandoned HRT overnight. Doctors stopped prescribing it.
The problem? The study had serious design limitations that took years to fully appreciate:
- The average age of participants was 63, meaning most women were more than a decade past menopause when they started hormones.
- The study used synthetic progestins, not bioidentical progesterone.
- It used oral conjugated equine estrogens, not transdermal estradiol.
- The absolute risk increases were tiny (8 additional breast cancer cases per 10,000 women per year).
- The estrogen-only arm of the study (for women without a uterus) actually showed a decrease in breast cancer risk.
The “Timing Hypothesis” and Modern Understanding
Key finding: When HRT is started within 10 years of menopause onset (or before age 60), it reduces cardiovascular disease risk and all-cause mortality. The protective effects are strongest with early initiation. Starting HRT more than 10 years after menopause, particularly in women over 60, is where risks begin to outweigh benefits for most patients.
This is called the “timing hypothesis,” and it has been supported by multiple subsequent analyses, including reanalysis of the original WHI data. The 2022 position statement from The Menopause Society (formerly NAMS) confirms that for healthy women under 60 or within 10 years of menopause, the benefits of HRT outweigh the risks.
The Lancet published a 2019 meta-analysis involving over 100,000 women, and the European Menopause and Andropause Society (EMAS) issued updated guidelines in 2021. The consensus across major medical organizations: individualized HRT, using the right formulations at the right time, is safe and beneficial for symptomatic women.
Benefits of HRT
| Benefit | Details | Strength of Evidence |
|---|---|---|
| Hot flash and night sweat relief | Reduces frequency and severity by 75% or more in most women | Strong (gold-standard RCTs) |
| Bone density protection | Reduces hip fracture risk by approximately 33% | Strong |
| Cardiovascular protection | When started early, reduces coronary heart disease events | Moderate to strong |
| Improved sleep | Reduces night sweats and may improve sleep quality independently | Moderate |
| Vaginal and urinary health | Reverses vaginal atrophy, reduces urinary tract infections | Strong |
| Mood and cognition | Reduces menopause-related depression and brain fog | Moderate |
| Skin health | Maintains collagen production and skin thickness | Moderate |
| Sexual function | Improves libido and reduces pain with intercourse | Moderate |
| Possible Alzheimer’s risk reduction | Early evidence suggests early HRT may reduce dementia risk | Emerging (observational data) |
Risks and Side Effects
Important Safety Information
HRT is not appropriate for everyone. Women with a history of estrogen-receptor-positive breast cancer, active liver disease, unexplained vaginal bleeding, or a history of blood clots or stroke should discuss alternatives with their doctor. Even for candidates who are good fits, regular monitoring (bloodwork, mammograms, pelvic exams) is essential.
Blood clots (venous thromboembolism): Oral estrogen increases clotting risk slightly. Transdermal estrogen (patches, creams, gels) does not appear to carry this same risk, making it the preferred route for women with clotting concerns or obesity.
Breast cancer: Combined estrogen-plus-progestin therapy (especially with synthetic progestins) is associated with a small increase in breast cancer risk after 5+ years of use. Estrogen alone does not increase this risk. Bioidentical progesterone appears to carry less risk than synthetic progestins, though long-term data is still maturing.
Stroke: Oral estrogen is associated with a slight increase in stroke risk. Transdermal estrogen at standard doses does not appear to carry this risk.
Gallbladder disease: Oral estrogen increases gallbladder disease risk. Again, transdermal delivery avoids this issue.
Common side effects (usually temporary): Breast tenderness, bloating, headaches, mood changes, and breakthrough bleeding. These typically resolve within the first 1 to 3 months as your body adjusts. Dose adjustments often help.
HRT for Men: The TRT Connection
When we talk about HRT for men, we are almost always talking about testosterone replacement therapy (TRT). Male hormone optimization has gained enormous traction in recent years as awareness of low testosterone and its effects has grown.
The symptoms of low testosterone in men mirror many menopause symptoms in women: fatigue, mood disturbance, cognitive decline, loss of muscle, increased body fat, reduced libido, and poor sleep. Diagnosis requires bloodwork showing total testosterone below approximately 300 ng/dL (though symptoms can appear at higher levels in some men, particularly when free testosterone is low).
TRT options for men include:
- Intramuscular or subcutaneous injections (testosterone cypionate or enanthate), typically weekly or twice weekly
- Topical gels or creams (applied daily)
- Subcutaneous pellets (inserted every 3 to 6 months)
- Nasal gels (Natesto, applied 2 to 3 times daily)
- Clomiphene citrate (off-label, stimulates natural production, preferred for men who want to preserve fertility)
For a deep dive into protocols, bloodwork targets, side effects, and monitoring, visit our full TRT guide.
What Does HRT Cost?
| Treatment | Monthly Cost (Without Insurance) | Monthly Cost (With Insurance) | Notes |
|---|---|---|---|
| Estradiol patch (generic) | $30 to $80 | $5 to $30 copay | Most insurance plans cover generic patches |
| Estradiol cream/gel | $50 to $150 | $10 to $40 copay | Divigel, Estrogel, and generics available |
| Oral estradiol | $15 to $40 | $5 to $15 copay | Very affordable generic option |
| Micronized progesterone (Prometrium) | $30 to $90 | $5 to $25 copay | Generic widely available |
| Testosterone cream (women) | $40 to $120 | Often not covered | Usually compounded at a pharmacy |
| Hormone pellets | $200 to $500 per insertion | Sometimes covered | Insertions every 3 to 6 months |
| TRT injections (men) | $40 to $100 | $10 to $30 copay | Testosterone cypionate is very affordable |
| Compounded bioidentical hormones | $80 to $300 | Usually not covered | Custom formulations from compounding pharmacies |
These numbers are approximate and vary by region, pharmacy, and specific formulation. Many clinics that specialize in hormone optimization charge a monthly membership fee (typically $100 to $300) that includes bloodwork, consultations, and medications.
How to Find a Provider
Not all doctors are comfortable prescribing or monitoring HRT. If your primary care physician dismisses your symptoms or refuses to discuss hormones, you have options:
- Look for a provider who specializes in hormone health. Board-certified endocrinologists, reproductive endocrinologists, and gynecologists with a focus on menopause are good starting points.
- Consider a functional or integrative medicine doctor. These practitioners often have more training in bioidentical hormones and individualized protocols.
- Check The Menopause Society’s provider directory at menopause.org for certified menopause practitioners (CMP or NCMP credential).
- Hormone optimization clinics specialize in exactly this. Many offer telemedicine consultations, at-home lab kits, and direct-to-patient medication shipping.
- Ask the right questions. Does the provider use bioidentical hormones? Do they monitor bloodwork regularly? Do they individualize dosing, or do they use a one-size-fits-all approach? A good provider will tailor your protocol to your labs, symptoms, and goals.
Frequently Asked Questions
Is HRT safe?
For most healthy women under 60 or within 10 years of menopause onset, yes. The benefits outweigh the risks when HRT is prescribed appropriately. The key factors are timing (earlier is better), formulation (bioidentical is preferred), and delivery method (transdermal is generally safer than oral for estrogen). Individual risk factors, including family history of breast cancer or blood clots, should be discussed with your doctor.
How long can I stay on HRT?
There is no mandatory stop date. The old “use it for five years and quit” advice was based on the WHI data and is now considered outdated for many women. Current guidelines support ongoing use as long as benefits outweigh risks, with annual reassessment. Some women stay on low-dose HRT well into their 70s for bone and brain protection. Your provider should review your situation annually.
Will HRT make me gain weight?
HRT itself does not cause weight gain. In fact, estrogen replacement can help prevent the shift toward abdominal fat that commonly happens in menopause. Some women notice mild water retention in the first few weeks, but this typically resolves. Progesterone can increase appetite in some women. Overall, most data suggests HRT is weight-neutral or slightly beneficial for body composition.
What about “natural” alternatives to HRT?
Supplements like black cohosh, red clover, and phytoestrogens (soy isoflavones) have been studied for menopause symptom relief. The evidence is mixed, and effects are generally much weaker than prescription HRT. Some women find lifestyle modifications (exercise, stress management, sleep hygiene, reducing alcohol) helpful for mild symptoms. For moderate to severe symptoms, especially hot flashes and vaginal atrophy, HRT remains the most effective treatment available.
Can I take HRT if I have had breast cancer?
This depends on the type of breast cancer. For women with a history of estrogen-receptor-positive breast cancer, systemic HRT is generally contraindicated. However, low-dose vaginal estrogen may be considered in some cases for severe urogenital symptoms, and non-hormonal options exist. Women with estrogen-receptor-negative breast cancer may have more flexibility, but this decision requires careful discussion with your oncologist.
Do I need bloodwork before starting HRT?
Yes. A baseline panel should include estradiol, progesterone, total and free testosterone, FSH, LH, thyroid panel (TSH, free T3, free T4), DHEA-S, and a metabolic panel. Many providers also check vitamin D, insulin, and inflammatory markers. Follow-up labs are typically done at 6 to 12 week intervals initially, then every 6 to 12 months once stable.
What is the difference between compounded and commercial HRT?
Commercial (FDA-approved) HRT products are manufactured to standardized doses and undergo rigorous quality testing. Compounded hormones are custom-mixed by a compounding pharmacy to a specific prescription. Both can use bioidentical hormones. The FDA does not regulate compounding pharmacies as strictly, so quality can vary. If you use compounded hormones, choose an accredited pharmacy (look for PCAB accreditation). Compounded options are useful when you need a dose or combination not available commercially.
Related Guides
Hormone health does not exist in isolation. If you are exploring HRT, these related treatments and topics may be relevant to you:
- Peptide Therapy: Growth hormone secretagogues, BPC-157, and other peptides that complement hormone optimization.
- Menopause Guide: A deep dive into the menopause transition, symptom management, and long-term health strategies.
- NAD+ IV Therapy: Cellular energy support that many patients combine with hormone therapy for anti-aging protocols.
References
- Rossouw JE, Anderson GL, Prentice RL, et al. “Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women’s Health Initiative Randomized Controlled Trial.” JAMA. 2002;288(3):321-333.
- Manson JE, Chlebowski RT, Stefanick ML, et al. “Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials.” JAMA. 2013;310(13):1353-1368.
- The 2022 Hormone Therapy Position Statement of The Menopause Society. Menopause. 2022;29(7):767-794.
- Collaborative Group on Hormonal Factors in Breast Cancer. “Type and Timing of Menopausal Hormone Therapy and Breast Cancer Risk: Individual Participant Meta-analysis of the Worldwide Epidemiological Evidence.” The Lancet. 2019;394(10204):1159-1168.
- Schierbeck LL, Rejnmark L, Tofteng CL, et al. “Effect of Hormone Replacement Therapy on Cardiovascular Events in Recently Postmenopausal Women: Randomised Trial.” BMJ. 2012;345:e6409.
- Bhasin S, Brito JP, Cunningham GR, et al. “Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.” The Journal of Clinical Endocrinology & Metabolism. 2018;103(5):1715-1744.
- European Menopause and Andropause Society (EMAS). “EMAS Position Statement: Individualized HRT for Menopausal Women.” Maturitas. 2021;154:62-70.
This page is for informational purposes only. It is not medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any hormone therapy regimen. Content last reviewed March 2026.
